日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial

帕博利珠单抗治疗晚期透明细胞妇科癌症患者:一项 II 期非随机临床试验

Kristeleit, Rebecca; Devlin, Michael-John; Clamp, Andrew; Gourley, Charlie; Roux, René; Hall, Marcia; Nirsimloo, Rachel; Kounnis, Valentinos; Sage, Lesley; Narayanan, Priya; Herrington, C Simon; Arora, Rupali; Farrelly, Laura; Hughes, Laura; Counsell, Nicholas; Miller, Rowan E

Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction

抗肿瘤IgE抗体MOv18诱导卵巢癌患者巨噬细胞发生过度炎症性极化,从而限制了免疫抑制性巨噬细胞与Treg细胞的相互作用。

Osborn, Gabriel; López-Abente, Jacobo; Adams, Rebecca; Laddach, Roman; Grandits, Melanie; Bax, Heather J; Chauhan, Jitesh; Pellizzari, Giulia; Nakamura, Mano; Stavraka, Chara; Chenoweth, Alicia; Palhares, Lais C G F; Evan, Theodore; Lim, Jessica Hui Cheah; Gross, Amanda; Moise, Lenny; Jatiani, Shashi; Figini, Mariangela; Bianchini, Rodolfo; Jensen-Jarolim, Erika; Ghosh, Sharmistha; Montes, Ana; Sayasneh, Ahmad; Kristeleit, Rebecca; Tsoka, Sophia; Spicer, James; Josephs, Debra H; Karagiannis, Sophia N

Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha

与 MOv18 IgE 相关的非过敏性荨麻疹样皮肤反应,MOv18 IgE 是一种首创的识别叶酸受体 α 的 IgE 抗体

Stavraka, Chara; Chauhan, Jitesh; Crescioli, Silvia; McSweeney, Sheila M; Pope, Amy; Gillett, Cheryl; Di Meo, Ashley; Prassas, Ioannis; Laddach, Roman; Stoker, Katie; McCraw, Alexandra J; Adams, Rebecca; Tull, Thomas J; Naban, Nabeel; Willsmore, Zena; Semkova, Kristina V; Grattan, Clive E H; McGrath, John; Till, Stephen J; Corrigan, Christopher J; Kristeleit, Rebecca; Tsoka, Sophia; Diamandis, Eleftherios P; Lacy, Katie E; Pinder, Sarah; Josephs, Debra H; Spicer, James; Bax, Heather J; Karagiannis, Sophia N

A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma

一项针对高级别胶质瘤或胶质母细胞瘤患者的口服利沙万布林的 1/2a 期剂量探索研究和生物标志物评估

Lopez, Juanita Suzanne; Haefliger, Simon; Plummer, Ruth; Clement, Paul M; Jeffry Evans, Thomas R; Läubli, Heinz; Roth, Patrick; Kristeleit, Rebecca; Brazil, Lucy; Tabatabai, Ghazaleh; Wick, Antje; Wunderlich, Benjamin; Beebe, Kirk; Eisner, Joel Robert; Lane, Heidi; Engelhardt, Marc; Kaindl, Thomas; Hau, Peter; Hundsberger, Thomas; Steinbach, Joachim

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study

DNA-PK抑制剂AZD7648单药或联合聚乙二醇化脂质体阿霉素治疗晚期癌症患者:一项首次人体I/IIa期研究的结果

Yap, Timothy A; LoRusso, Patricia; Miller, Rowan E; Kristeleit, Rebecca; Paulovich, Amanda G; McMorn, Stephen; Oplustil O'Connor, Lenka; Lombardi, Benedetta; Marco-Casanova, Paola; Gangl, Eric T; Patel, Bharat; O'Connor, Mark J; Dean, Emma; Zviezdin, Roman; Plummer, Ruth

A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients

一项针对复发性、铂耐药性、高级别浆液性卵巢癌 (PROC) 患者的 tilvestamab (BGB149) 的 1b 期多中心剂量递增、安全性和药代动力学研究

Sooi, Kenneth; Tan, Tuan Zea; Kim, Jae-Weon; Lee, Jung Yun; Kim, Byoung-Gie; Micklem, David; Jackson, Akil; Pinato, David J; Gourley, Charlie; Kristeleit, Rebecca; Blagden, Sarah P; Bjorge, Line; Tan, David Shao Peng

Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)

一项 II 期随机研究比较了多斯利单抗单药或联合贝伐单抗与非铂类化疗治疗复发性妇科透明细胞癌的疗效(DOVE/APGOT-OV7/ENGOT-ov80)

Lee, Jung-Yun; Tan, David; Ray-Coquard, Isabelle; Lee, Jung Bok; Kim, Byoung Gie; Van Nieuwenhuysen, Els; Huang, Ruby Yun-Ju; Tse, Ka Yu; González-Martin, Antonio; Scott, Clare; Hasegawa, Kosei; Wilkinson, Katie; Yang, Eun Yeong; Lheureux, Stephanie; Kristeleit, Rebecca

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

BRCA1二级剪接位点突变驱动外显子跳跃和PARP抑制剂耐药性。

Nesic, Ksenija; Krais, John J; Wang, Yifan; Vandenberg, Cassandra J; Patel, Pooja; Cai, Kathy Q; Kwan, Tanya; Lieschke, Elizabeth; Ho, Gwo-Yaw; Barker, Holly E; Bedo, Justin; Casadei, Silvia; Farrell, Andrew; Radke, Marc; Shield-Artin, Kristy; Penington, Jocelyn S; Geissler, Franziska; Kyran, Elizabeth; Betsch, Robert; Xu, Lijun; Zhang, Fan; Dobrovic, Alexander; Olesen, Inger; Kristeleit, Rebecca; Oza, Amit; McNeish, Iain; Ratnayake, Gayanie; Traficante, Nadia; DeFazio, Anna; Bowtell, David D L; Harding, Thomas C; Lin, Kevin; Swisher, Elizabeth M; Kondrashova, Olga; Scott, Clare L; Johnson, Neil; Wakefield, Matthew J

Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial

每周一次紫杉醇联合维司他尼与单用紫杉醇治疗铂耐药卵巢高级别浆液性癌患者的疗效和安全性:OCTOPUS 多中心 II 期随机临床试验

Banerjee, Susana; Giannone, Gaia; Clamp, Andrew R; Ennis, Darren P; Glasspool, Rosalind M; Herbertson, Rebecca; Krell, Jonathan; Riisnaes, Ruth; Mirza, Hasan B; Cheng, Zhao; McDermott, Jacqueline; Green, Clare; Kristeleit, Rebecca S; George, Angela; Gourley, Charlie; Lewsley, Liz-Anne; Rai, Debbie; Banerji, Udai; Hinsley, Samantha; McNeish, Iain A